Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation.
about
Platelet signaling: a complex interplay between inhibitory and activatory networksBreaking the mold: transcription factors in the anucleate platelet and platelet-derived microparticlesEndothelial PPAR-γ Protects Against Vascular Thrombosis by Downregulating P-Selectin ExpressionSignificanceThrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex.15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells.Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseasesFarnesoid X Receptor and Its Ligands Inhibit the Function of Platelets.Mechanism of the anti-platelet effect of natural bioactive compounds: role of peroxisome proliferator-activated receptors activation.Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated PlateletsPPARγ agonists negatively regulate αIIbβ3 integrin outside-in signaling and platelet function through up-regulation of protein kinase A activity.LXR as a novel antithrombotic targetStaphylococcus aureus lipoteichoic acid inhibits platelet activation and thrombus formation via the Paf receptor.RXR Ligands Negatively Regulate Thrombosis and Hemostasis.New mechanisms of antiplatelet activity of nifedipine, an L-type calcium channel blocker.A sticky story for signal transducer and activator of transcription 3 in platelets.Non-genomic effects of nuclear receptors: insights from the anucleate platelet.Effect of supplementation with an 80:20cis9,trans11 conjugated linoleic acid blend on the human platelet proteomeAMP-Activated Protein Kinase Mediates the Antiplatelet Effects of the Thiazolidinediones Rosiglitazone and Pioglitazone.The HIV protease inhibitor, ritonavir, dysregulates human platelet function in vitro
P2860
Q26765384-4E90A823-DE5E-4644-8D2B-B2AA0C46E72DQ26830366-13B39067-84D9-4825-A02F-47B2B693163FQ27342480-E776E8E3-5932-4185-A141-EC4E611EB86CQ33897766-5261059C-2195-4143-B775-3A2033678CAAQ36174169-838F5524-CAF7-4EB7-9DDF-110068F66FDDQ36252847-0D83329A-4D93-429E-98A6-B779F867D8A9Q36918509-3E05FFF4-BF0C-43FF-9BE7-58B9AADBBE70Q37485728-66D3E323-038F-436E-94CD-803D089A4354Q38163612-4986EAC0-90C9-4CF1-91F5-A559DADB28A0Q41118234-23E0BDBD-5CBB-4722-9FDD-D827C0949088Q41871753-B87833A9-805B-4A93-939C-5CB0D3047147Q41969289-F55FCE12-6D0D-4E3E-87E9-39C481947FF1Q42029477-29DE42BC-6EFE-4C33-97DB-0C2A28C01C2BQ42290465-06CF2B8E-F5D9-4710-BCA5-639D8FC4F8F0Q42592882-5DE0E9D8-33C9-40AB-997E-38BFC7DCA063Q43125680-54274C4E-51A9-42CC-87D8-C19517584217Q49922734-E057B61D-15B0-413A-98EA-0193C262585CQ54750996-8ADFAAA9-3D2B-4BF8-A5D6-A48655D0710EQ55034947-35DF90E4-6AFB-44E8-8658-E43A94312E9CQ57166290-930448BD-1334-4556-A237-0D1EEB17E8AD
P2860
Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Non-genomic effects of PPARgam ...... timulated platelet activation.
@en
type
label
Non-genomic effects of PPARgam ...... timulated platelet activation.
@en
prefLabel
Non-genomic effects of PPARgam ...... timulated platelet activation.
@en
P2093
P2860
P1476
Non-genomic effects of PPARgam ...... timulated platelet activation.
@en
P2093
J M Gibbins
L A Moraes
M Spyridon
R E L Atherton
W J Kaiser
P2860
P304
P356
10.1111/J.1538-7836.2009.03732.X
P577
2009-12-21T00:00:00Z